A molecular link between E2F-1 and the MAPK cascade

Jianli Wang1, Wen Hong Shen1, Yan J Jin1

  • 1Department of Radiation Oncology, College of Physicians and Surgeons, Columbia University, New York, New York 10032.

Insights

Transcription factor E2F-1 regulates apoptosis and tumor suppression by activating MKP-2 (MAPK phosphatase-2). This E2F-1/MKP-2 pathway is crucial for cellular response to oxidative stress and suppressing tumor formation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Transcription factor E2F-1 is known to mediate apoptosis and suppress tumorigenesis.
  • The precise mechanisms underlying E2F-1's function in these processes remain largely undefined.

Purpose of the Study:

  • To elucidate the role of E2F-1 in regulating apoptosis and tumor suppression.
  • To identify downstream targets of E2F-1 involved in oxidative stress response.

Main Methods:

  • Investigated the transcriptional regulation of MKP-2 (MAPK phosphatase-2) by E2F-1.
  • Utilized chromatin immunoprecipitation assays to assess E2F-1 binding to the MKP-2 promoter.
  • Assessed apoptosis and tumor formation in response to E2F-1 and MKP-2 modulation.

Main Results:

  • E2F-1 acts as a transcriptional regulator of MKP-2, a dual specificity protein phosphatase (DUSP4).
  • E2F-1 is essential for the induction of MKP-2 expression following oxidative stress.
  • The E2F-1/MKP-2 pathway mediates apoptosis under oxidative stress and MKP-2 suppresses tumor formation.

Conclusions:

  • E2F-1 is a transcriptional activator of MKP-2.
  • MKP-2 is an essential mediator of cell death within the E2F-1 pathway.
  • Targeting the E2F-1/MKP-2 pathway offers potential for novel cancer therapeutics.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...